Partner Identification

Objective :

Partners Identification for client’s early-stage oncology based clinical product for late-stage clinical development and commercialization.

Problem Statement:

A medium pharmaceutical client based in the US, with innovative formulations to treat Head and Neck Cancer, involved DelveInsight to identify a co-development partner, for the US and European region. The client was interested to involve a pharmaceutical company with experience around oncology, capabilities to develop the product through its clinical development cycle and also support commercial manufacturing for launching the product in the two regions.

Our Methodology:

• Oncology Market Assessment
• Assessment of Companies with Development and Commercialization Capabilities
• Deal/Investment Assessment
• Interest in Client’s candidate
• 5-10 Potential Partners

Results:

• Extensive Listing of Companies with requisite capabilities
• Matrix Analysis of the top 25 companies researched.
• The client could assess the Top 5-10 companies that fit their strategic needs and were interested in the partnership.
• Final Engagement through DelveInsight to take the discussions forward.